|
Market Closed -
Nasdaq
16:00:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 9.340 USD | -1.37% |
|
-4.21% | -48.79% |
| 08-05 | ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026 | |
| 08-05 | Earnings Flash (ADMA) ADMA Biologics, Inc. Reports Q2 Revenue $124.4M, vs. FactSet Est of $125.3M | MT |
| Market Cap | 2.09B 1.81B 1.69B 1.54B 2.9B 200B 2.94B 19.86B 7.78B 100B 7.85B 7.68B 333B | P/E 2026 * |
11.5x | P/E 2027 * | 9.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 1.81B 1.69B 1.54B 2.9B 200B 2.94B 19.86B 7.78B 100B 7.85B 7.68B 333B | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 2.99x |
| Free-Float |
90.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ADMA Biologics, Inc.
| 22-12-07 | Wall Street lager gesloten | |
| 22-12-07 | Wall Street koerst af op vlak slot | |
| 22-12-07 | Wall Street verder omlaag bij opening | |
| 22-12-07 | Futures Wall Street wijzen omlaag | |
| 17-03-30 | Chinesischer Investor hat Interesse an Biotest |
| 1 day | -1.37% | ||
| 1 week | -4.21% | ||
| Current month | +10.40% | ||
| 1 month | +7.23% | ||
| 3 months | +12.94% | ||
| 6 months | -41.44% | ||
| Current year | -48.79% |
| 1 week | 9.24 |  | 9.96 |
| 1 month | 8.16 | | 10.35 |
| Current year | 7.21 | | 18.95 |
| 1 year | 7.21 | | 20.46 |
| 3 years | 3.06 | | 25.67 |
| 5 years | 1.01 | | 25.67 |
| 10 years | 1.01 | | 25.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 49 | 2011-09-30 |
Paul Kohler
DFI | Director of Finance/CFO | 49 | 2026-02-25 |
| Compliance Officer | 39 | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jerrold Grossman
BRD | Director/Board Member | 78 | 2006-12-31 |
Steven Elms
CHM | Chairman | 62 | 2012-03-29 |
Adam Grossman
BRD | Director/Board Member | 49 | 2006-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/24/26 | Tax | Compliance Officer | -3,177 | 0.0014% | ||
| 7/16/26 | Free | Chief Financial Officer | 221,493 | 0.0956% | ||
| 2/26/26 | Other | Chief Financial Officer | 149,185 | 0.0627% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -4.21% | -45.03% | +117.72% | 2.09B | |
| +0.30% | -0.26% | +38.86% | +1.15% | 80.48B | |
| -1.02% | -1.34% | -2.54% | +30.42% | 50.63B | |
| -0.37% | -5.13% | +9.80% | +166.58% | 47.57B | |
| +17.25% | +14.09% | -41.83% | -41.67% | 45.84B | |
| -0.32% | +0.98% | +50.90% | -20.02% | 30.9B | |
| +1.80% | +7.77% | +130.05% | -39.33% | 25.73B | |
| +2.78% | +1.60% | +42.08% | +92.34% | 25.03B | |
| +1.36% | +1.15% | -5.15% | +207.31% | 21.16B | |
| +1.09% | +4.76% | +64.56% | +126.22% | 16.75B | |
| Average | +1.80% | -0.00% | +24.17% | +64.07% | 34.62B | |
| Weighted average by Cap. | +2.33% | -0.12% | +24.26% | +43.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 535M 462M 434M 395M 743M 51.19B 753M 5.08B 1.99B 25.64B 2.01B 1.97B 85.3B | 700M 605M 567M 517M 971M 66.96B 985M 6.65B 2.61B 33.55B 2.63B 2.57B 112B |
| Net income | 191M 165M 155M 141M 265M 18.29B 269M 1.82B 712M 9.16B 718M 703M 30.48B | 248M 214M 201M 183M 343M 23.68B 348M 2.35B 921M 11.86B 930M 910M 39.46B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | US$9.340 | -1.37% | 1,497,295 |
| 26-08-14 | US$9.470 | +0.64% | 1,308,626 |
| 26-08-13 | US$9.410 | -3.78% | 3,107,174 |
| 26-08-12 | US$9.780 | -1.26% | 1,919,177 |
| 26-08-11 | US$9.905 | +1.59% | 2,538,537 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADMA Stock
Select your edition
All financial news and data tailored to specific country editions
